At some centers, I know that induction with venetoclax and azacytidine/decitabine/low dose cytarabine or liposomal cytarabine/daunorubicin (CPX-351) for patients with newly diagnosed AML has been administered in the outpatient setting. However, in these centers (such as Moffitt Cancer Center), there...